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Abstract
At least 65% of all small molecule drugs on the market today are natural products, however, re-isolation of previously identified
and characterized compounds has become a serious impediment to the discovery of new bioactive natural products. Here, genetic
knockout of an unusual non-ribosomal peptide synthetase (NRPS) C-PCP-C module, aziA2, is performed resulting in the accumula-
tion of the secondary metabolite, dimethyl furan-2,4-dicarboxylate. The cryptic metabolite represents the first non-azinomycin
related compound to be isolated and characterized from the soil bacterium, S. sahachiroi. The results from this study suggest that
abolishing production of otherwise predominant natural products through genetic knockout may constitute a means to “activate” the
production of novel secondary metabolites that would otherwise lay dormant within microbial genome sequences.
Findings
It has become increasingly apparent that microbial diversity in
nature far exceeds that reflected in laboratory strain collections.
The advent of microbial genomics and the availability of
published genome sequences suggest, that as much as 90% of
the chemical potential of these organisms remain “silent” within
the genome [1,2]. While the biosynthetic machinery appears
functional, the genetic loci are frequently (but not always) unex-
pressed. The activation of such pathways has garnered interest
from the scientific community. Quorum sensing refers to the
process by which microorganisms communicate (within a single
bacterial species or between diverse species) and alter their gene
expression through production of certain signaling molecules
[3]. In this regard, the culturing of microbial communities or the
co-culture of two specific microbial organisms has been
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Figure 1: Schematic diagram illustrating the phenotypic effects arising through deletion of the aziA2 gene.
successfully implemented to “activate” secondary metabolite
production [4,5]. In some instances, shot-gun cloning and
expression of soil samples and bacterial symbiont genomes
have led to the discovery of a representative set of natural prod-
ucts and enzymes, albeit typically of small biosynthetic path-
ways (less than 10 kb) [6,7]. Direct manipulation, “induced”
biosynthetic activation, of a sequenced cluster has also met with
some success. The Aspergillus nidulans genome was mined for
cryptic orphan gene clusters from which a single, unexpressed
PKS-NRPS hybrid was identified. The expression of the gene
cluster was activated by the ectopic expression of a specific
regulatory gene, apdR, resulting in the production of the aspyri-
dones [8]. Sometimes, a cryptic pathway is fully expressed and
has simply gone unnoticed. In this regard, a genome-isotopic
approach has proven useful where stable isotope-labeled puta-
tive precursors of the orphan pathway are fed to the organism
and used to screen extracts of the fermentation broth, to iden-
tify metabolites containing the labeled precursors [9,10].
Here, we have carried out a functional knockout of aziA2 within
the azinomycin gene cluster of Streptomyces sahachiroi
[11,12]. The gene encodes a NRPS (non-ribosomal peptide
synthetase, an enzyme involved in the biosynthesis of various
peptide containing secondary metabolites) module of unusual
domain architecture consisting of condensation, peptidyl carrier
protein, and condensation domains (C-PCP-C), respectively.
Gene inactivation led to the abolishment of azinomycin produc-
tion, confirming the involvement of aziA2 in the biosynthesis of
the antitumor agent [11,13] and also led to overproduction of a
compound, dimethyl furan-2,4-dicarboxylate. The metabolite
represents one of many cryptic pathway metabolites from the
S. sahachiroi genome and is the first non-azinomycin related
compound to be isolated from the S. sahachiroi strain
(Figure 1). Previously isolated metabolites consisted of azino-
mycin intermediates lacking the 1-azabicyclo[3.1.0] ring
system, including naphthoate and naphthoate epoxide deriva-
tives [11].
The aziA2 disruption construct (pKC-AziA2) was generated by
replacing the mid-portion (1500 bp) of the gene with a thio-
strepton resistance marker within the vector pKC1139. The
plasmid was introduced into S. sahachiroi by conjugal transfor-
mation. Single crossover mutants were initially selected by
culturing the strain on both apramycin and thiostrepton MS-agar
plates. The double crossover mutants were subsequently gener-
ated from the single crossover mutants by growing the colonies
on MS-agar plates in the presence of only thiostrepton antibi-
otic, resulting in the occurrence of double crossover events. The
S. sahachiroi/ΔaziA2 disruptants were confirmed by PCR and
Southern hybridization of thiostrepton resistant and apramycin
sensitive colonies. Direct comparison of HPLC profiles of the
wild-type and ΔaziA2 crude organic extracts were striking
(Figure 2). The ΔaziA2 mutant gave a single major peak.
3-Methoxy-5-methyl-1-naphthoic acid was detected in trace
amounts (suggesting that the metabolite is released in solution
from the PKS and not directly transferred to that of a subse-
quent NRPS module) and complete abolishment of the azino-
mycins was observed. The production of the naphthoic acid
derivative and lack of azinomycin production confirms the
involvement of aziA2 (C-PCP-C NRPS module) in azinomycin
biosynthesis; given the unique domain architecture of this
module, this is a significant finding as non-functional NRPS
modules have been found imbedded in certain gene clusters
[14].
Structural characterization of the major metabolite was carried
out using LC–MS analysis and 1D and 2D cryoprobe NMR
spectroscopy (data provided in Supporting Information File 1).
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Figure 2: HPLC profiles of (A) S. sahachiroi wild-type and (B) ΔaziA2 crude organic extracts.
The molecular formula was established as C8H8O5 based upon
a molecular ion peak observed by LC–APCIMS at m/z
185.0453 [M + H]+ and GC–MS. The GC–MS fragmentation of
the compound matched that provided in the Ultra GC–DSQ
(ThermoElectron, Waltham, MA) GC–MS database. The struc-
ture of the compound was determined by NMR analysis in
CDCl3 (Table 1). The presence of two O-CH3 groups at C-2’
(δc 51.99, δH 3.94) and C-2” (δc 52.31, δH 3.88) and double
bonds in the aromatic ring at C-3 (δc 117.07, δH 7.49, d,
J = 0.811) and C5 (δc 150.14 δH 8.14, d, J = 0.845) were
observed by 1H NMR, DEPT, HMQC and HMBC. C-1” (δc
158.53), C-2 (δc 145.44), C-5 (δc 150.14) and C-1’ (δc 162.34)
signals were detected by 13C NMR (Table 1). The data identi-
fied the compound as dimethyl furan-2,4-dicarboxylate, which
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has been previously observed in microbial head-space or vapor
phase extracts and its structure determined through chemical
synthesis [15]. The biosynthetic origin of dimethyl furan-2,4-
dicarboxylate could be polyketide derived where the furan ring
system could be envisioned to form through nucleophilic attack
of an epoxide as in the case with monensin and other similar
natural products [16]. Alternatively, the biosynthesis might
involve the dimerization of pyruvate [17-19]. Examination of a
draft genome sequence of the S. sahachiroi strain has impli-
cated a pyruvate aldolase and methyltransferase containing gene
cluster as well as potential polyketide gene clusters containing
methyltransferase genes, which will be evaluated in due course
through genetic knockout experiments of the ΔaziA2 mutant
strain.
Table 1: 13C NMR (δC) and 1H NMR (δH, J in Hz) 500 MHz spectro-
scopic data in CDCl3.
Position δC δH (J in Hz) HMBC (H→C)
1
2 145.44, CO
3 117.07, CH 7.49, (0.811) d 2,4,5,1”
4 120.96, C
5 150.14, CH 8.14, (0.845) d 2,3,4,1’
1’ 162.34, C
1” 158.53, C
2’ 51.99, CH3 3.94, s 1”
2” 52.32, CH3 3.88, s 1’
Disruption of the aziA2 gene gave overproduction of the cryptic
metabolite dimethyl furan-2,4-dicarboxylate and led to
complete abolishment of azinomycin production. It is the first
non-azinomycin related metabolite to be reported from the
S. sahachiroi strain, a microorganism that has been mined for
its natural product constituents since 1954 [20]. These results
demonstrate that while some disruption strains will certainly be
more easily characterized than others, the act of simply inacti-
vating genes from highly expressed or represented biosynthetic
gene clusters can be a useful strategy toward revealing or
unmasking novel natural products or cryptic metabolites for
subsequent isolation and characterization. Secondary metabo-
lite production by microorganisms is often viewed as a line of
defense against competing microbes for nutrients. Natural prod-
ucts like azinomycin, a DNA crosslinking agent, can offer a
means of protection to the producing organism. It is tempting to
speculate that when biosynthetic pathways of these metabolites
are inactivated, the microorganism begins to adapt and evolve
in an effort to develop new self defense mechanisms. Such
adaptations (which may or may not be immediately useful to the
host) can lead to the production of new metabolites such as
dimethyl furan-2,4-dicarboxylate.
Experimental
DNA manipulation and methods
Conventional recombinant DNA techniques were utilized for
plasmid and genomic DNA isolation, restriction enzyme diges-
tion, agarose gel electrophoresis, and DNA ligations [21]. DNA
sequencing was performed using ABI BigDye chemistry at the
Gene Technologies Lab, Texas A&M University. The
computer-based analysis and comparisons of nucleotide and
protein sequences were performed with BLAST, FASTA,
CLUSTALW and GENEDOC programs. See Supporting Infor-
mation File 1 for details on bacterial strains, plasmids, PCR
primer sequences, and bacterial culture conditions.
Construction of disruption plasmid pKCAziA2
Disruption of aziA2 was performed using a homologous recom-
bination approach with pKC1139. PCR with primer pairs
aziA2UF/aziA2UR and aziA2DF/aziA2DR was utilized to
generate a 930 bp upstream fragment and 923 bp downstream
fragment relative to aziA2. Amplification was carried out as
follows: initial denaturation at 98 °C for 30 s; 30 total cycles of
denaturation for 10 s; annealing at 66.4 °C for aziA2UF/
aziA2UR and 62 °C for aziA2DF/aziA2DR for 40 s; polymer-
ization at 72 °C for 60 s and finally gap filing at 72 °C for
10 min. The amplified DNA fragment of azia2-U was digested
with HindIII/XbaI (azia2-U) and XbaI/EcoRI (azia2-D) and
cloned into the corresponding sites of pKC1139, resulting in
pKCA2UD. pKCA2UD was digested with XbaI and ligated
with the thiostrepton-resistance gene (1056 bp), which was
amplified with TsrF/TsrR primers using the same amplification
condition as detailed for aziA2DF/aziA2DR, to give the final
disruption recombinant plasmid pKC-AziA2, where aziA2 is
replaced by tsrr in-frame.
Conjugal transformation with plasmid
pKCAziA2
pKC-AziA2 was transformed into E. coli S-17, a donor host and
subsequently transferred into wild type, S. sahachiroi by
conjugal transformation, as described by Kieser et al. (with
some modification) [22] for deletion with a replicative plasmid
as mediated by homologous recombination. From an overnight
5 mL culture of E. coli donor strain, 100 µL was transferred
into 100 mL fresh LB medium and cultured for 4 h. The cells at
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OD600 0.6 were harvested, washed twice and solubilized in
500 µL of 2xYT medium. Spores of S. sahachiroi were
prepared in MS agar plates and collected after one week. Spores
were washed, heat shocked at 70 °C for 10 min and incubated at
37 °C for 4 h. Following incubation, they were washed and
resuspended in 500 µL of 2xYT medium. These recipient cells
were mixed with an equal volume of E. coli donor cells and
200 µL of the mixture were plated on MS-agar plates. The
plates were incubated at 30 °C for 18 h, and overlayed with
1 mL water containing nalidixic acid (500 µg), to inhibit the
growth of E. coli, and apramycin (25 µg) to select S. sahachiroi
exconjugants. Incubation at 30 °C was continued for 6–8 days
to allow growth of the exconjugants. Apramycin exconjugants
were screened for several generations until the exconjugants
were found to be apramycin sensitive and thiostrepton resistant
to detect the double crossover allelic exchange. For further
confirmation of deletion of aziA2 from S. sahachiroi, genomic
DNA was isolated from both S. sahachiroi wild-type and aziA2
knockout strains (S. sahachiroi/ΔaziA2) and PCR performed.
The AziA2UF/TsrR and TsrF/AziA2DR primer set was
utilized: initial denaturation at 98 °C for 30 s; 30 total cycles of
denaturation for 10 s; annealing at 64.5 °C for 40 s; polymeriza-
tion at 72 °C for 60 s and finally gap filing at 72 °C for 10 min.
Southern hybridization was carried out following standard pro-
cedures [21] with a radioactive 32P-ATP labeled probe. The
probe was generated through PCR amplification using the aziA2
probe-F/aziA2 Probe R set of primers and following the same
PCR condition as detailed above.
Fermentation and analysis of secondary
metabolites
Fermentation was carried out in 10 L following established pro-
cedures [23]. After 72 h of incubation, the culture broth was
centrifuged and the supernatant extracted with dichloromethane
(2× the volume of the medium). The organics were concen-
trated in vacuo and analyzed by reversed-phase HPLC. The
column, Phenomenex, Columbus 5µ C8 100A (250 × 3.20 mm
5 µ) was equilibrated with 10% of A (75% MeOH/25%
isopropanol) and 90% of B (water) and run with the following
program: Time 0 min A-10%; 1 min A-10%; 5 min A-35%;
14 min A-95%; 15 min A-95%; 20 min A-10%; 25 min A-10%;
60 min A-100%. This was carried out at a flow rate of
0.75 mL/min in 254 nm UV. The same program was used for
LC–APCI analysis. For GC–MS analysis, the sample was
diluted 1:10 in DCM and was performed on an Ultra GC/DSQ
(ThermoElectron, Waltham, MA). A Rxi-5ms gas chromato-
graphic column was utilized with dimensions of 60 m length,
0.25 mm i.d., and 0.25 μm film thickness (Restek; Bellefonte,
PA). Helium was implemented as a carrier gas at a constant
flow rate of 1.5 mL/min. The transfer line and ion source were
held at 250 °C. The column temperature was maintained at
50 °C for 5 min then raised to 320 °C for 20 °C/min. Mass
spectra were acquired in full scan mode in the range of
30–500 m/z.
Cryoprobe NMR analysis
NMR spectra were acquired on a Bruker Avance III 500 MHz
instrument at 25 °C, equipped with a 5 mm H–C–N cryoprobe.
The sample was dissolved in 125 μL CDCl3 and contained in a
3 mm wilmad 335 pp NMR tube. Proton, carbon, Dept 90, Dept
135, HMQC and HMBC spectra were recorded. A 30° observe
pulse was used to acquire the 1H NMR spectrum, while a 45o
pulse was used to obtain the 13C NMR spectrum.
Supporting Information
Supporting Information File 1
Details on genetic knockout, Southern blot analysis,
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